United Capital Financial Advisors LLC Makes New $817,000 Investment in Agilent Technologies, Inc. $A

United Capital Financial Advisors LLC acquired a new stake in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,154 shares of the medical research company’s stock, valued at approximately $817,000.

A number of other hedge funds also recently added to or reduced their stakes in A. Core Wealth Advisors LLC bought a new stake in Agilent Technologies during the 4th quarter valued at $26,000. SHP Wealth Management purchased a new stake in shares of Agilent Technologies during the 4th quarter worth $26,000. Navalign LLC bought a new stake in Agilent Technologies during the fourth quarter valued at about $27,000. Cedar Mountain Advisors LLC purchased a new position in Agilent Technologies in the first quarter valued at about $27,000. Finally, MV Capital Management Inc. bought a new position in Agilent Technologies in the fourth quarter worth about $28,000.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. The Goldman Sachs Group raised their price target on shares of Agilent Technologies from $155.00 to $175.00 and gave the company a “buy” rating in a report on Thursday. Morgan Stanley raised their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. HSBC decreased their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Sanford C. Bernstein boosted their target price on Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies Trading Up 0.4%

Shares of Agilent Technologies stock opened at $154.47 on Monday. The firm’s 50 day simple moving average is $140.30 and its two-hundred day simple moving average is $127.04. The firm has a market capitalization of $43.63 billion, a price-to-earnings ratio of 30.41, a PEG ratio of 2.34 and a beta of 1.25. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $163.75. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the firm posted $1.37 earnings per share. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.